Table 2.

Clinical outcomes of the participants.

Outcome	Current use	Non-use	p-value	OR	95% CI
Discharge mRS
0–3	297/582 (51.0)	823/1,530 (53.8)	0.256	1.117	0.923–1.352
4–6	285/582 (49.0)	707/1,530 (46.2)
30-day mRS
0–3	313/577 (54.2)	819/1,532 (53.5)	0.747	0.969	0.800–1.174
4–6	264/577 (45.8)	713/1,532 (46.5)
90-day mRS
0–3	373/577 (64.7)	963/1,528 (63.0)	0.491	0.932	0.763–1.138
4–6	204/577 (35.3)	565/1,528 (37.0)
Discharge death	16/587 (2.7)	80/1,553 (5.2)	0.016*	0.516	0.299–0.890
30-day death	67/577 (11.6)	248/1,532 (16.2)	0.009*	0.68	0.510–0.908
90-day death	88/577 (15.3)	303/1,528 (19.8)	0.016*	0.728	0.561–0.943

^*p < 0.05.

mRS, modified Rankin Scale; OR, odds ratio.